Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy

Leuk Lymphoma. 2010 Dec;51(12):2299-302. doi: 10.3109/10428194.2010.518654. Epub 2010 Oct 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Brain Diseases / drug therapy*
  • Brain Diseases / etiology
  • Cyclophosphamide / administration & dosage*
  • Dexamethasone / administration & dosage*
  • Humans
  • Hyperammonemia / complications
  • Hyperammonemia / drug therapy*
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Pyrazines / administration & dosage*
  • Remission Induction
  • Time Factors
  • Treatment Outcome

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
  • Cyclophosphamide